A share price of Genpact Ltd [G] is currently trading at $37.50, up 15.74%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The G shares have gain 10.78% over the last week, with a monthly amount glided 17.67%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Genpact Ltd [NYSE: G] stock has seen the most recent analyst activity on July 17, 2024, when JP Morgan upgraded its rating to a Neutral and also revised its price target to $40 from $43. Previously, Mizuho started tracking the stock with Neutral rating on January 30, 2024, and set its price target to $40. On December 15, 2023, downgrade downgraded it’s rating to Neutral but maintained its price target of $38 on the stock. JP Morgan downgraded its rating to a Underweight but stick to its price target of $40 on August 22, 2023. Citigroup downgraded its rating to a Neutral and reduced its price target to $42 on July 18, 2023. JP Morgan downgraded its rating to Neutral for this stock on December 15, 2022, and downed its price target to $50. In a note dated February 14, 2022, Cowen downgraded an Market Perform rating on this stock and revised its target price from $57 to $51.
Genpact Ltd experienced fluctuations in its stock price throughout the past year between $29.41 and $38.51. Currently, Wall Street analysts expect the stock to reach $40.33 within the next 12 months. Genpact Ltd [NYSE: G] shares were valued at $37.50 at the most recent close of the market. An investor can expect a potential return of 7.55% based on the average G price forecast.
Analyzing the G fundamentals
Trailing Twelve Months sales for Genpact Ltd [NYSE:G] were 4.59B which represents 6.40% growth. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.29 and Total Capital is 0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 36.03 points at the first support level, and at 34.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 38.36, and for the 2nd resistance point, it is at 39.21.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Genpact Ltd [NYSE:G] is 1.89. As well, the Quick Ratio is 1.89, while the Cash Ratio is 0.76. Considering the valuation of this stock, the price to sales ratio is 1.47, the price to book ratio is 2.86 and price to earnings (TTM) ratio is 10.58.
Transactions by insiders
Recent insider trading involved Tyagarajan N. V., Director, that happened on Jun 05 ’24 when 1000.0 shares were sold. Chief Accounting Officer, Klunk Donald J completed a deal on Feb 15 ’24 to sell 1845.0 shares. Meanwhile, SVP & Chief Legal Officer White Heather sold 11450.0 shares on Jan 22 ’24.
